ArticleCirculation. Cardiovascular quality and outcomes2018
Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population.
Article in Circulation. Cardiovascular quality and outcomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 59 citations in OpenAlex.
- Mortality and morbidity after transcatheter aortic valve implantation compared to an age- and sex-matched control population: a population-based study from the SWEDEHEART registry.European heart journal. Quality of care & clinical outcomes · 2025Article
- Quality of Life After Mitral Transcatheter Edge-to-Edge Repair According to Baseline Tricuspid Regurgitation.Structural heart : the journal of the Heart Team · 2025Article
- Geriatricians' role in the management of aortic stenosis in frail older patients: a decade later.European geriatric medicine · 2024Article
- The Impact of Frailty and Surgical Risk on Health-Related Quality of Life After TAVI.Journal of cardiovascular development and disease · 2024Review
- Machine Learning Identification of Modifiable Predictors of Patient Outcomes After Transcatheter Aortic Valve Replacement.JACC. Advances · 2024Article
- A Comprehensive Geriatric Workup and Frailty Assessment in Older Patients with Severe Aortic Stenosis.Journal of clinical medicine · 2024Review
- TAVR in Older Adults: Moving Toward a Comprehensive Geriatric Assessment and Away From Chronological Age:JACC. Advances · 2024Article
- Associations of Sarcopenia and Body Composition Measures With Mortality After Transcatheter Aortic Valve Replacement.Circulation. Cardiovascular interventions · 2024Article
- Quality of Life After Transcatheter Aortic Valve Replacement in Normal-Flow, Low-Gradient Aortic Stenosis.JACC. Advances · 2023Article
- CardioVision: A fully automated deep learning package for medical image segmentation and reconstruction generating digital twins for patients with aortic stenosis.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2023Article
- Heart Failure after Aortic Valve Replacement: Incidence, Risk Factors, and Implications.Journal of clinical medicine · 2023Review
- Metabolic Signatures of Cardiac Dysfunction, Multimorbidity, and Post-Transcatheter Aortic Valve Implantation Death.Journal of the American Heart Association · 2023Article
- Sarcopenia and Cardiovascular Diseases.Circulation · 2023Review
- Asymptomatic Aortic Stenosis in an Older Patient: How the Geriatric Approach Can Make a Difference.Diagnostics (Basel, Switzerland) · 2023Article
- Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis.American heart journal · 2023Article
- First description and validation of a new method for estimating aortic stenosis burden and predicting the functional response to TAVI.Frontiers in cardiovascular medicine · 2023Article
- Left ventricular stroke volume index following transcatheter aortic valve replacement is an early predictor of 1-year survival.Clinical cardiology · 2023Article
- Review
- A new integrative approach to assess aortic stenosis burden and predict objective functional improvement after TAVR.Frontiers in cardiovascular medicine · 2023Article
- Peri-procedural code status for transcatheter aortic valve replacement: Absence of program policies and standard practices.Journal of the American Geriatrics Society · 2022Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 4 institutions in 1 country.
Funding
Abstract
Background Among clinical trial patients at high surgical risk, a model has been developed and externally validated to estimate patient risk for poor outcomes after transcatheter aortic valve replacement (TAVR). How this model performs in lower risk and unselected patients is not known. We sought to examine and optimize the performance of the TAVR poor outcome risk model among patients in the US Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Methods and Results Among 13 351 patients who underwent TAVR at 252 US sites between November 9, 2011 and June 30, 2015, the rate of poor outcome at 1 year after TAVR was 38.9%, which was because of death in 20.7% and poor quality of life or quality of life decline in 18.2%. The rate of poor outcome has decreased slightly over time, from 42.0% in 2012 to 37.8% in 2015 ( P for trend=0.076). The original TAVR poor outcome risk model did not calibrate well on this population. We then reestimated the intercept and coefficients in the model and retested model performance, after which it performed well (both overall and in subgroups), with a C index 0.65 and excellent calibration. Conclusions In a large cohort of unselected patients in the United States, we found that while a substantial minority of patients continue to have a poor outcome after TAVR, outcomes have slowly improved over time. After recalibration, the TAVR poor outcome risk model performed well. This model could potentially be used before TAVR to help patients have appropriate expectations of recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.